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ToelucidatetherelationshipbetweenDNAadductformationandtumorigenesis, anumberofexperimentshavebeen
conductedtomeasureDNAadductsintargettissuesfromexperimentalaninalsduringcontinuousexposuretocarcinogens.
Withaflatoxins, aromaticamines, andpolycyclic aromatic hydrocarbons, tumorinductionappearstobeassociated with
themajorDNAadductdetected, whereaswithN-nitrosaminestheresponseisnormallycorrelatedwith minorformsof
DNAdamage. Duringcontinuouscarcinogenadministration, steady-stateadductconcentrationsaregenerally obtained
inthetargettissues, andthereisoftenalinearcorrelationbetweenthecarcinogenconcentrationandthesteady-stateDNA
adductlevel. Eeeptionsexistwhenthemechanismofactivationchangesorwiththeonsetofsignificanttoxicity.Steady-state
DNA adduct levels areoften linearly related tothetumorigenic response. Carcinogen-inducedcell proliferation occurs




Recently published reports have described the presence of
DNA adducts in individuals exposed to chemical carcinogens
[reviewed inPoirierandWeston(1)]. Themajorityofthese car-
cinogen exposures appeartobechronic in nature, andthe DNA
adductconcentrations presumably reflectsteady-state levelsthat
are the product ofconcomitant adduct formation and removal.
In spiteofthisachievement, thecorrelation between the meas-
ured DNA adduct levels andhuman cancer riskis notknownand
maybeexceedingly complex. Tohelpelucidatethisrelationship,
a number ofinvestigations have been conducted using animal
models in which DNA adducts were measured during the
chronic administration oftumorigenicdosingregimens. Inthis
review, we discuss these studies, emphasizing four classes of
chemical carcinogens forwhichthereis substantial evidenceof
human exposure: N-nitrosamines, aflatoxins, aromatic amines,
andpolycyclic aromatichydrocarbons. Inaddition, wewill com-
pare the DNA adducts that have been detected during these
tumorigenic dosing studies with those identified in humans.
N-Nitrosamines
Humans areexposed toN-nitrosamines from awidevariety of
sources including foods, beverages, tobacco, cosmetics, cutting
oils, hydraulic fluids, and rubber products (2). As with the
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majority ofchemical carcinogens, N-nitrosamines tend to be
chemically inertcompounds that mustbe metabolized to reac-




genic potential indicates that alkylation of exocyclic oxygens





investigated by Boucheron et al. (6), who treated rats with
various concentrations ofN-nitrosodiethylamine for up to 70
days. In the target organ, the liver, the concentration of 04-
ethylthymidine increasedrapidly ateachdoseforaboutthefirst
14 days, whereupon steady-state adduct levels were obtained
(Fig. IA). Atsteady state(e.g., after49daysofcontinuous treat-
ment; Fig. IB), thelevelsof04-ethylthymidine weredependent
ondose, withessentially alinearcorrelationbeingobservedbe-
tweendoseandadductconcentration upto40ppm. At 100ppm
N-nitrosodiethylamine, the steady-state levels of 04-ethyl-
thymidine were similar to those at 40 ppm (Fig. IB). This ap-
parentfailuretoformmoreadductsmaybeduetoincreasedcell
turnover (7).
A similar study was conducted by Belinsky et al. (8), who
measured 06-methylguanine in DNA from differentcell types
inthelungsofratstreatedsubcutaneouslythreetimesperweek
for 4 weeks with five different doses of 4-(methylnitrosa-
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FIGURE 1. Accumulation of04-ethylthymidine in hepatic DNA during con-
tinuous exposureofrats as a function of(A)timeduring exposure to0.4(U),
1 (@), 4 (A), 10(O), 40 (0), or 100 (A) ppmN-nitrosodiethylamine for up
to 70 days or (B) dose after exposure from 0.4 to 100 ppm N-nitroso-




FIGURE 2. Relationship between (A) administered dose of4-(methylnitros-
amino)-1-(3-pyridyl)-1-butanone (NNK) and concentration of 06_
methylguanine in Claracellsofrats afterdosing three times per week for4
weeks; (B)administereddoseofNNKand lungtumorincidenceafter2 years
followingdosing threetimes perweek for20weeks; and (C) concentration
of06-methylguanine inClaracellsofratsafterdosingthreetimes perweek
for 4 weeks and lung tumor incidence after 2 years following dosing three
times per week for 20 weeks. Data are from Belinsky et al. (8).
06-methylguanine in Clara cells exhibited nonlinear kinetics
with respecttodose, withadduct formation occurring to amuch
greater extent atlowerdosesthanwouldhavebeenexpected from
extrapolation of higher doses (Fig. 2A). This nonlinearity in
response wasattributed totheexistenceofahigh-affinitypathway
for the activation of NNK at low concentrations of the car-
cinogen. Since the kinetics oftumor induction (Fig. 2B) were
similar to thoseofthe adduct concentration in Clara cells (Fig.
2A), there was a linear correlation between the level of 06-
methylguanine inthesecellsandthetumorincidence (Fig. 2C).
In the liverand nasal passages, whereNNK caused tumors on-
ly athigh doses, adductand tumorprofilesdid notcorrespond.
This suggests that in these tissues both adduct formation and
cytotoxicity are necessary for tumorigenesis.
Inanotherstudy, inwhich rats weretreated withfourIPdoses
ofNNK, alinearrelationship wasobservedbetweenhepatic con-
centrations ofN7-methylguanineandamountofNNKgiven(9).
This was notthe situation inthe lung, which, as intheBelinsky
etal. study (8), was attributed totheexistenceofahigh-affinity
activation pathway in lung tissue at low doses ofNNK.
Withtheexception oftheinduction oforal cancerinsnuffdip-
pers (10,11), there is no conclusiveepidemiological evidence for
thecarcinogenicity ofN-nitrosamines in humans. Nevertheless,
the types of DNA adducts formed in exposed individuals are
similar tothoseobserved inexperimental animals. Forexample,
HerronandShank(12) found N7-and06-methylguanine inthe
liverofavictimpoisonedwithN-nitrosodimethylamine. More
recently, Umberhauer etal. (13) detected 06-methylguanine in
stomach andesophagealtissueandesophageal tumorDNA from
Chinese cancer patients. This adduct was also found at lower
levels in the sametissues in Europeans, who are at a lower risk
fordeveloping esophageal tumors. Similarresults wereobtained
by Saffhill etal. (14) whencomparing individuals in Southeast
Asia with those from England. Likewise, Huh etal. (15) found
higher levels of04-ethylthymine in DNA from Japanese liver
cancerpatients compared tonontumor-bearing controlpatients.
06-Methylguanine and 06-ethylguanine havealsobeendetected
in peripheral lung DNA of smokers and nonsmokers, but the



































moldy cereals, grains, and nuts (17,18). Fourmajornaturally oc-
curring aflatoxins, aflatoxin B, (AFB,), aflatoxinB2, aflatoxin
GI, andaflatoxin G2, havebeencharacterized, withAFB1 being
the most abundant as well as the most carcinogenic. The
metabolic activation of AFB, involves oxidation of the 8,9-
olefinic bond to give AFBI-8,9-oxide (19), which reacts with
DNA to yield trans-8,9-dihydro-8-(deoxyguanosin-7-yl)-9-
hydroxy AFBI [AFBI-N7-dG (20)]. AFB,-N7-dG carries a
positive charge and is therefore unstable. It can undergo
depurination to give an apurinic site within the DNA (20) or
base-catalyzedopeningoftheimidazole ring toyieldpyrimidine
adducts (21).
In experimental animals, AFBI is normally hepatocarcino-
genic withtherelativeorderofsensitivity being: trout > rat >>
hamster = mouse salmon(17,22). Duringthecontinuousad-
ministrationofAFB,, steady-statehepaticDNAadductlevels are
obtained inapproximately2-6weeks in rats (23,24)and 3 weeks
in trout(22). Inboth speciesthesteady-state adductconcentra-
tions appear tobe linearly related totheconcentration ofAFBI
administered chronically (24-26). Moreover, ifthesteady-state
adduct levels are compared to the hepatic tumor incidence, a
nearly identical linear relationship isobtained forboth species
(27).
Inhumans, there is apositivecorrelationbetweentheamount
ofAFB, ingestedandtheincidenceofliver cancer(17,18). Fur-
thermore, AFBI DNAadductshavebeendetectedintissuesand
urine from exposed humans (28-30). More recently, a highly
significantcorrelation wasobservedbetweendailyconsumption
of AFB, and concentration of serum adducts of AFB, and
urinary AFB,-N7-Gua (31,32), which presumably represent
steady-state levels.
Aromatic Amines
Human exposure toaromatic aminesandamides occurs from
a number of sources including various industrial processes,
cigarette smoke, andcertainfoods(33). Thereisalsowidespread
exposure to nitropolycyclic aromatic hydrocarbons, which are
products of incomplete combustion and are converted to aro-
matic aminesby nitroreduction (33). In experimental animals,
major target organs for tumor induction fromthesecompounds
include the liver, urinary bladder, mammary gland, and in-
testine. In these tissues, the major adducts are formed through
covalent linkage of the amine or amide nitrogen to C-8 of
guanine, while minoradducts arisefrom reactions betweenthe
carbons ortho to the amine oramide nitrogen andtheexocyclic
nitrogens and oxygens ofguanine and adenine (33).
Duringthecontinuousadministration ofaromatic amine car-
cinogens to rodents, steady-state blood (34,35), tissue (34),
hepatic DNA adduct (36-38), and bladder DNA adduct (38)
concentrations are obtained after approximately one month of
dosing. These steady-state levels are dose-related (34,37,38)
(Fig. 3A), and a linearcorrelation exists betweenthe DNA ad-
ductconcentration andthehepatic tumor incidence in rats (37)
and female mice (38) (Fig. 3B) administered 2-acetylamino-
fluorene and in female mice (39) treated with4-aminobiphenyl.
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FIGURE 3. Relationshipbetween(A)thedoseof2-acetylaminofluorene fedto
female mice for 28 days and the concentration of N-(deoxyguano-
sin-8-yl)-2-aminofluorene in liver(0) and bladder(U) DNA and (B) con-
centrationofN-(deoxyguanosine-8-yl)-2-aminofluorene inliver(0)andblad-
der(U)offemalemicefed2-acetylaminofluorene for28daysandthetumor
incidence in the same tissues after feeding the same concentrations for 33
months. Data are from Poirier etal. (38).
3B)andmalemiceadministered4-aminobiphenyl (39), therela-
tionshipbetweenthebladdertumoryieldandDNAadductcon-
centration isnonlinear. Thisnonlinearity inresponseappearsto










presenceof4-aminobiphenyl DNAadducts inhumanlung and
bladdersamples(16,45,46), withthelevels inthebladderbeing
significantly higher in smokers (46).
Polycyclic Aromatic Hydrocarbons
Polycyclic aromatic hydrocarbons (PAHs) are byproducts of
combustion processes resulting inubiquitous human exposure
tothisclassofcarcinogens(47). Inexperimentalanimals, PAHs
induce primarily skin, stomach, lung, and mammary gland
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tumors (48), andthis appears tobetheresultofmetabolic con-
versiontodihydrodiol epoxides (49). Generally, guanineisthe
preferred base for adduct formation with these reactive elec-
trophiles; however, depending onthePAH, considerable binding
canalsooccurwithadenineandcytosine. Furthermore, because
dihydrodiol epoxidesareopticallyactive(49), theextentofreac-
tion with aparticular nucleic acidbasewill depend onthepar-
ticular stereoisomer being considered (50).
Recently, thekineticsofDNAadductformationhavebeenex-
amined in theepidermis ofmice administered benzo[a]pyrene
topically once a week for 29 weeks (51). Steady-state adduct
levels appeared to beobtained after 3 weeks ofdosing, and the
adductlevelswerelinearlyrelatedtodoseupto32isgpertreat-
ment, whereupon a plateau occurred. As the skin tumor in-
cidence wasnotlinearlycorrelatedtothedose, itwas suggested
thatcell proliferation plays anessential role intheinductionof
these tumors. Inpreliminary studies inourlaboratory, alinear
relationship hasbeenfoundbetweentheadductlevelsinlungand
forestomachandtheconcentrationofbenzo[a]pyrenefedtomice
for 1 month atdoses upto50mg/kgdiet (CulpandBeland, un-
publishedobservation). Theinductionofforestomachtumorsin
miceappearstobemarkedly nonlinearwithdose(52); thus, as
with bladdertumors in mice (38,39), cellproliferation may be
an additional critical factor fortumorigenesis inthis tissue.
PAHs are probably carcinogenic in humans (53), and DNA
adducts from these compounds have been detected in human
populations (1). Inasmuch ascigarettesmokecontains substan-
tialquantitiesofPAHs(54), anumberofstudieshavecompared
PAH-DNAadductconcentrations invarioustissuesfromsmok-
ers and nonsmokers. Immunoassays with antibodies elicited
against (±)-anti-benzo[a]pyrene-7,8-dihydrodiol-9,10-
epoxide-modified DNAhave revealed that smokers oftenhave
somewhat higher PAH-DNA adduct levels than nonsmokers
(55-59), although this is notalways the case (16,60-64). More
dramatic differences have been found using 32P-postlabeling,
which is generally specific for "aromatic" DNA adducts. In
several studies, smokers have had higher levels ofdiscrete ad-
ducts (55,56,65) or a larger diffuse areaofadducts (58,66-68)




by subjecting the DNA to immunoaffinity chromatography
followed by high-pressure liquid chromatography and syn-
chronous fluorescence spectroscopy, and also by gas chro-
matography-mass spectrometry in the case of the placental
DNA; however, the extentofsmoking did not always correlate
with the adductconcentrations observed.
In another study (71), benzo[a]pyrene diol epoxide adducts
were detected in alveolar macrophages by synchronous fluo-
rescence spectrometry, andthelevelsdidappeartodependupon
smoking status. Otherexposure-relatedincreases inPAH-DNA
adducts, asdeterminedbyimmunoassays, havebeenreportedin
peripheral bloodlymphocytesfromironfoundryworkersandin-
dividuals ingesting charcoal-broiled beef, and positive im-
munochemical results havealsobeenfoundwithbloodsamples
from coke-oven workers, foundry workers, roofers, and
firefighters (1).
Summary
Inthis review wehaveconsideredtheDNAadducts formed in
animal models from four classes ofchemical carcinogens for
whichthereis substantial evidence forhumanexposure. Some




pearstobechemical-classspecific. Thus, tumorinduction from
N-nitrosamines is best associated with 06-guanine and 04-
thymine substitution. Foraflatoxins, theresponseiscorrelated
with reaction at N7 of guanine; with aromatic amines,
C8-guanine substitutiongenerally appearsto bethecritical le-
sion; and forPAHs, N2ofguanineand/orN6ofadenine appear
tobe the important sites for substitution.
T1umorsinducedbyN-nitrosaminesareassociatedwiththefor-
mation of minor adducts (e.g., 06-alkylguanine and 04--




continuous carcinogenadministration, andthistypically occurs
afterapproximately 1 monthofchronic dosing. Because DNA
adduct levels reach steady state, an estimation ofthe risk for
developing atumor cannot be obtained from the DNA adduct
concentrationbyitself, buthastoincludeboththeDNAadduct
concentration and the length ofcarcinogen exposure.
Thereisoftenalinearcorrelationbetweenthechronically ad-
ministereddoselevelsandthesteady-state DNAadductconcen-
trations intargettissues (e.g., 2-acetylaminofluorene inmouse
liver and bladder; Fig. 3A). Exceptions exist when the mech-
anismofactivationchanges (e.g., NNK inratlung; Fig. 2A) or
withtheonsetofsignificanttoxicity (e.g.,N-nitrosodiethylamine
in rat liver; Fig. IB).
Steady-stateDNAadductlevelsareoftenlinearlyrelatedtothe
tumorigenic response (e.g., 2-acetylaminofluorene in mouse
liver; Fig. 3B). When significantdeviations fromlinearity are
observed (e.g., 2-acetylaminofluorene in mousebladder; Fig.
3B), carcinogen-inducedcellproliferation appearstobeanad-
ditional componentfortumorigenesis. Becausethisresponseoc-
cursatrelatively highcarcinogendoses, itmay notbegermane
to mosthumanexposure scenarios.
DNA adducts can be detected in humans, and these adducts
correspondtothosefoundinexperimentalanimals. Itshouldbe
possible, therefore, to use DNA adduct data in animals to es-
timate human cancer risk.
This manuscript was presented at the Conference on Biomonitoring and
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